NCT06730555

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Conditions

• HIV Infections

Interventions

Type	Name	Description
BEHAVIORAL	ACCESS Intervention	Participants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.
BEHAVIORAL	Control Group	Participants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.

Timeline

• Start date: 2025-06-27
• Primary completion: 2028-08-01
• Completion: 2028-08-01
• First posted: 2024-12-12
• Last updated: 2026-02-03

Locations

1 site across 1 country: United States